Japan vs Rwanda: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Japan
96.0%
in 2025
Rwanda
96.0%
in 2025
Japan rank
27th
Rwanda rank
27th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Japan
- Rwanda
How they compare
Japan currently reports 96.0% against 96.0% in Rwanda, a difference of 0.0%.
The two have swapped places 8 times across 18 shared years of data; in 2008 it was Rwanda ahead.
Japan ranks 27th and Rwanda ranks 27th of 194 countries.
Across the 3 decades both report, Japan averaged higher in 1 and Rwanda in 1.
Head to head by decade
| Decade | Japan | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 88.1% | 97.7% | 9.6% | Rwanda |
| 2020s | 95.3% | 94.0% | 1.3% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Japan or Rwanda?
- Japan, at 96.0% against 96.0% in Rwanda as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Japan and Rwanda?
- 0.0%, with Japan ahead.
- How many years of comparable data are there for Japan and Rwanda?
- 18 years are reported by both, from 2008 to 2025.
- How do Japan and Rwanda rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Japan ranks 27th and Rwanda ranks 27th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.